Press Releases


Lilly to Participate in Evercore ISI 3rd Annual HealthCONx Conference

November 24, 2020

Tags |  Financial

INDIANAPOLIS , Nov. 24, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 3 rd Annual HealthCONx Conference on Tuesday, December 1, 2020 . Michael Mason , Lilly senior vice president and president of Lilly Diabetes and Connected Care, will participate in a




Lilly to Participate in Wolfe Research Virtual Healthcare Conference

November 12, 2020

Tags |  Financial

INDIANAPOLIS , Nov. 12, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a virtual fireside




Lilly to Participate in Bernstein Operational Decisions Conference

November 12, 2020

Tags |  Financial

INDIANAPOLIS , Nov. 12, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020 . Andrew Adams , Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly 's anti-COVID-19




Lilly Announces Webcast to Provide an Overview of Tirzepatide Phase 3 clinical program

November 11, 2020

Tags |  Financial

Webcast will not include results from any Phase 3 clinical trials INDIANAPOLIS , Nov. 11, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Friday, November 20, 2020 to provide an overview of the tirzepatide Phase 3 type 2 diabetes clinical trial program in




Lilly Reports Third-Quarter Financial Results, Updates Guidance

October 27, 2020

Tags |  Financial

- Revenue in the third quarter of 2020 increased 5 percent driven by volume growth of 9 percent, while on a year-to-date basis revenue increased 6 percent driven by volume growth of 12 percent.   - Key growth products launched since 2014, consisting of Taltz, Trulicity, Verzenio, Jardiance,




Lilly Declares Fourth-Quarter 2020 Dividend

October 19, 2020

Tags |  Financial

INDIANAPOLIS , Oct. 19, 2020 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2020 of $0.74 per share on outstanding common stock. The dividend is payable December 10, 2020 , to shareholders of record at the close of




Lilly Confirms Date and Conference Call for Third-Quarter 2020 Financial Results Announcement

October 8, 2020

Tags |  Financial

INDIANAPOLIS , Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2020 financial results on Tuesday, October 27, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial




Lilly to Participate in Cantor Fitzgerald Virtual Global Healthcare Conference

September 11, 2020

Tags |  Financial

INDIANAPOLIS , Sept. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 17, 2020 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a virtual




Lilly to Participate in Morgan Stanley Global Healthcare Conference

September 11, 2020

Tags |  Financial

INDIANAPOLIS , Sept. 11, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2020 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a virtual fireside




Lilly Announces Webcast to Discuss ESMO 2020 Presentations

September 10, 2020

Tags |  Financial

INDIANAPOLIS , Sept. 10, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, September 21, 2020 to discuss the company's presentations at the 2020 European Society for Medical Oncology (ESMO) Virtual Congress . The webcast will begin at 3:00 p.m.